Florian B. Lagler

1.9k total citations
56 papers, 807 citations indexed

About

Florian B. Lagler is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Florian B. Lagler has authored 56 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 15 papers in Pediatrics, Perinatology and Child Health and 12 papers in Molecular Biology. Recurrent topics in Florian B. Lagler's work include Lysosomal Storage Disorders Research (15 papers), Metabolism and Genetic Disorders (12 papers) and Pharmaceutical studies and practices (12 papers). Florian B. Lagler is often cited by papers focused on Lysosomal Storage Disorders Research (15 papers), Metabolism and Genetic Disorders (12 papers) and Pharmaceutical studies and practices (12 papers). Florian B. Lagler collaborates with scholars based in Austria, Germany and Netherlands. Florian B. Lagler's co-authors include Ania C. Muntau, Søren W. Gersting, Kristina Kemter, Marta K. Danecka, Adelbert A. Roscher, Jenny M. Kindblom, Steven Hirschfeld, Christian P. Sommerhoff, Francjan J. van Spronsen and Hartmut Glossmann and has published in prestigious journals such as Blood, The American Journal of Human Genetics and Human Molecular Genetics.

In The Last Decade

Florian B. Lagler

50 papers receiving 793 citations

Peers

Florian B. Lagler
Hilary Vallance Canada
Jean M. Lacey United States
Pablo Sanjurjo Spain
Joannie Hui Hong Kong
Chloe Miu Mak China
Yukiko Hasuike Japan
Wolfgang Strobl Austria
James P. Loehr United States
T. E. Stacey United Kingdom
Albert H. Bootsma Netherlands
Hilary Vallance Canada
Florian B. Lagler
Citations per year, relative to Florian B. Lagler Florian B. Lagler (= 1×) peers Hilary Vallance

Countries citing papers authored by Florian B. Lagler

Since Specialization
Citations

This map shows the geographic impact of Florian B. Lagler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian B. Lagler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian B. Lagler more than expected).

Fields of papers citing papers by Florian B. Lagler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian B. Lagler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian B. Lagler. The network helps show where Florian B. Lagler may publish in the future.

Co-authorship network of co-authors of Florian B. Lagler

This figure shows the co-authorship network connecting the top 25 collaborators of Florian B. Lagler. A scholar is included among the top collaborators of Florian B. Lagler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian B. Lagler. Florian B. Lagler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harmatz, Paul, et al.. (2025). Safety of anesthesia in mucopolysaccharidoses - A comparative retrospective cohort study on more than 600 cases. Molecular Genetics and Metabolism. 145(2). 109108–109108.
2.
Feillet, François, Jean‐Baptiste Arnoux, Alberto Burlina, et al.. (2024). Long‐term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study. Journal of Inherited Metabolic Disease. 48(1). e12796–e12796. 1 indexed citations
3.
Werner, Helene, Markus A. Landolt, Andreas Hahn, et al.. (2024). Living with Pompe disease: results from a qualitative interview study with children and adolescents and their caregivers. Orphanet Journal of Rare Diseases. 19(1). 358–358.
4.
Lagler, Florian B., et al.. (2023). Individual Treatment Trials—Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis?. Pharmaceuticals. 16(3). 416–416. 2 indexed citations
5.
6.
7.
Beckmann, Jürgen, Oliver Mayer, Peter Ewert, et al.. (2022). Quality of life in patients with Fabry’s disease: a cross-sectional study of 86 adults. Cardiovascular Diagnosis and Therapy. 12(4). 426–435. 7 indexed citations
8.
Smits, Anne, Pieter Annaert, Giacomo Cavallaro, et al.. (2021). Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. British Journal of Clinical Pharmacology. 88(12). 4965–4984. 30 indexed citations
9.
Wortmann, Saskia B., Johan L.K. Van Hove, Terry G. J. Derks, et al.. (2020). Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 136(9). 1033–1043. 93 indexed citations
10.
Hirschfeld, Steven, Florian B. Lagler, & Jenny M. Kindblom. (2020). Prerequisites to support high-quality clinical trials in children and young people. Archives of Disease in Childhood. 106(5). 423–428. 4 indexed citations
11.
Schreuder, Michiel F., Michiel Dalinghaus, Christoph Male, et al.. (2020). Pharmacology of enalapril in children: a review. Drug Discovery Today. 25(11). 1957–1970. 18 indexed citations
12.
Lagler, Florian B., Steven Hirschfeld, & Jenny M. Kindblom. (2020). Challenges in clinical trials for children and young people. Archives of Disease in Childhood. 106(4). 321–325. 31 indexed citations
13.
Muntau, Ania C., Darius J. Adams, Amaya Bélanger-Quintana, et al.. (2019). International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria. Molecular Genetics and Metabolism. 127(1). 1–11. 43 indexed citations
14.
Lagler, Florian B.. (2019). Current and Emerging Therapies for Mitochondriopathies. Handbook of experimental pharmacology. 261. 57–65. 4 indexed citations
15.
Rauch, Elisabeth, Florian B. Lagler, Harald Herkner, et al.. (2018). A survey of medicine use in children and adolescents in Austria. European Journal of Pediatrics. 177(10). 1479–1487. 9 indexed citations
16.
Löscher, Wolfgang N., Martina Huemer, Thomas M. Stulnig, et al.. (2017). Pompe disease in Austria: clinical, genetic and epidemiological aspects. Journal of Neurology. 265(1). 159–164. 27 indexed citations
17.
Dalinghaus, Michiel, Michael Burch, András Szatmári, et al.. (2017). Question 1: How safe are ACE inhibitors for heart failure in children?. Archives of Disease in Childhood. 103(1). 106.1–109. 5 indexed citations
18.
Ramusovic, Sergej, Stephanie Läer, Bernd Meibohm, Florian B. Lagler, & Thomas Paul. (2013). Pharmacokinetics of intravenous amiodarone in children. Archives of Disease in Childhood. 98(12). 989–993. 10 indexed citations
19.
Scholl‐Bürgi, Sabine, Jörn Oliver Sass, Peter Heinz‐Erian, et al.. (2009). Changes in plasma amino acid concentrations with increasing age in patients with propionic acidemia. Amino Acids. 38(5). 1473–1481. 15 indexed citations
20.
Lagler, Florian B., et al.. (1976). [Toxicological investigations of the combination sulfamoxole/trimethoprim, a new broad-spectrum chemotherapeutic (author's transl)].. PubMed. 26(42). 634–43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilary Vallance Breakdown of academic impact, for papers by Jean M. Lacey Breakdown of academic impact, for papers by Pablo Sanjurjo Breakdown of academic impact, for papers by Joannie Hui Breakdown of academic impact, for papers by Chloe Miu Mak Breakdown of academic impact, for papers by Yukiko Hasuike Breakdown of academic impact, for papers by Wolfgang Strobl Breakdown of academic impact, for papers by James P. Loehr Breakdown of academic impact, for papers by T. E. Stacey Breakdown of academic impact, for papers by Albert H. Bootsma
Rankless by CCL
2026